- The Intent to Compete is Now Closed
@OregonNVC- OregonNVC: When planning at a high level, it can be easy to forget the simple things... Stay positive! http://t.co/RUpTKklQ
- OregonNVC: Business plans can change on a dime- especially when working with tech. Don't overlook these industry trends. http://t.co/1jt9ybRJ
- OregonNVC: What can you learn from HuffPo's favorite entrepreneurs from last year? http://t.co/PNTaOOnJ
Past Winners
NVC 2011
The 2011 New Venture Championship was held on April 7-9, 2011 at the Monaco Hotel and White Stag Building in Portland, Oregon. Twelve teams from all over the United States, along with four teams from Canada, China, and Thailand came together to test their mettle and improve as ventures, make connections with top executives and investors, and of course, compete for $50,000+ in prizes. Special thanks go out to all the teams who submitted intents to compete, our sixteen teams who came to the competition, and all the volunteers who committed their time and enthusiasm. Without you, NVC would not be possible.
First Place Winner
University of Texas at Austin
Venture: ClearBrook Imaging
Concept: ClearBrook will add material value and reduce risks linked to developmental level medical device companies. ClearBrook will accomplish this by furthering the development of the device throughout all stages of testing in the regulatory process, successfully completing each consecutive regulatory hurdle and data submission requirement, resulting in a development cycle with reduced risk and statistically significant efficacy and safety data.
Team: Ryan Miller, David Mortellaro, and Jimmy Su
Faculty Advisor: Gary Cadenhead
Second Place
SASIN Institute of Technology at Chulalongkorn University
Venture: aQuainnova
Third Place Winner
University of Oregon
Venture: VisiRay
NVC 2010
First Place Winner
University of Louisville
Venture: NanoMark Therapeutics
Concept: NanoMark Therapeutics has developed Aura, for the treatment of ovarian cancer. Aura targets cancer cells only, minimizing negative side effects to healthy cells. Aura also reduces dosage requirements 200-fold. AUra passed Round 1 of animal testing with compelling results. This patent-pending drug can treat and diagnose 12 different cancer types.
Team: Sham Kakar, Gary Degen, Cohin Kakar, Dave Noack and Viji Sundar
Second Place Winner
University of Oregon
Venture: Mosaic Genetics
Third Place Winner
University of Arkansas
Venture: Green Valley Solar